Today morning, stock futures were near the flatline as the S&P 500 was on course to have its best first-quarter performance in five years.
Top stock gainers
Despite missing market expectations in Q4, RH (RH) shares surged 8% on the anticipation of better home furnishing performance. In Q1, demand is likely to rise in the positive mid-single digits and revenue to drop in the low single digits. 6%–7% operational margin and 12%–13% EBITDA are goals. Demand is expected to climb 12%–14% and sales 8%–10% in FY2024. The adjusted operating margin and EBITDA margin are estimated to be 13%–14% and 12%–13%, respectively.
Akebia Therapeutics (AKBA) shares rose 25% after the FDA approved Vafseo® (vadadustat) Tablets for chronic kidney disease (CKD) anemia in adults on dialysis for at least three months. Vafseo, a once-daily oral medicine, boosts erythropoietin production to treat anemia. Vafseo can be sold in 37 countries after INNO2VATE and post-marketing safety data from Japan, where it was released in 2020. Through its skilled marketing team and relationship with CSL Vifor, Akebia hopes to make Vafseo the new standard of treatment for dialysis patients in the U.S.
Top stock losses
After a mixed FQ3 and a negative forecast, MillerKnoll (MLKN) shares fell 12%. The business estimates 4Q24 net sales to be $880M to $920M, below the consensus of $961.38M, due to third-quarter demand and a weak macroeconomic climate. Adjusted diluted EPS is expected to be $0.49–$0.57, below the consensus of $0.68. Midpoint of earnings range suggests 29% year-over-year rise from adjusted diluted earnings per share in fourth quarter of prior fiscal year. Full-year adjusted diluted earnings per share are expected to be between $1.90 and $1.98, below the consensus of $2.07.
After filing a prospectus for a $300 million class A common equity offering, Intuitive Machines (LUNR) shares fell over 8%. Selling shareholders resold 159.81 million class A common stock, according to the prospectus.
Must read book about investing – check here Today’s Top Performers Today’s Top Performers Today’s Top Performers Today’s Top Performers
After reporting 8% Y/Y subscription revenue growth in 4Q24, DocuSign (NASDAQ:DOCU) shares rose 10%. Electronic signature business predicts 1Q25 revenue of $704M to $708M, above analysts’ $699.1M forecast. DocuSign expects sales of $2.91B to $2.92B this year, with consensus of $2.91B. Customer adoption of Contract Lifecycle Management and eSignature in StateRAMP-authorized environments was also emphasized by the organization.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.
MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.
Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.
Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.